Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2018 Publisher: SPONSOR: Teva Pharma (New Zealand) Limited, PO Box 128 244, Remuera, Auckland 1541, Telephone: 0800 800 097
Arrow – Ornidazole, 500 mg, film coated tablet.
| Pharmaceutical Form |
|---|
|
White to slightly yellowish, cylindrical, biconvex film coated tablets. |
Each tablet contains 500 mg of ornidazole.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ornidazole |
Ornidazole is indicated for the treatment of Bacterial vaginosis. It is effective against Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia (Giardia intestinalis), and also against certain anaerobic bacteria such as Bacteroides and Clostridium spp., Fusobacterium spp., and anaerobic cocci. |
| List of Excipients |
|---|
|
Maize starch |
PVC/Aluminium foil blister packs. Pack size of 10 tablets.
Not all pack types or pack sizes may be marketed.
SPONSOR: Teva Pharma (New Zealand) Limited, PO Box 128 244, Remuera, Auckland 1541, Telephone: 0800 800 097
Date of first approval: 17 March 2011
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
